Perpetual Ltd’s Biogen BIIB Stock Holding History

Perpetual Ltd’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,797	Closed	-$226K	–	404
2025 Q2	$226K	Hold	1,797	–	–	﹤0.01%	404
2025 Q1	$246K	Buy	+1,797	New	+$257K	﹤0.01%	390
2023 Q2	–	Sell	-1,129	Closed	-$314K	–	467
2023 Q1	$314K	Buy	+1,129	New	+$312K	﹤0.01%	440

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Perpetual Ltd's BIIB Position: Q3 2025 in Review

Perpetual Ltd sold out of Biogen (BIIB) in Q3 2025, closing a stake of 1,797 shares — an estimated $226K sold.

Perpetual Ltd first reported a position in BIIB in Q1 2023 and held it in 3 quarters. The position peaked at $314K in Q1 2023. 905 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

Perpetual Ltd reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
Perpetual Ltd sold 1,797 Biogen shares in Q3 2025, an estimated $226K.
Perpetual Ltd first reported a position in Biogen in Q1 2023 and held it in 3 quarters.
Perpetual Ltd's Biogen position peaked at $314K in Q1 2023.
905 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Perpetual Ltd's 13F filing for Q3 2025, filed 10 Oct 2025.